DAWN – Day One Biopharmaceuticals, Inc.
DAWN
$6.65Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $674,057,280.00
EPSttm : -0.65
Day One Biopharmaceuticals, Inc
$6.65
Float Short %
13.77
Margin Of Safety %
Put/Call OI Ratio
0.06
EPS Next Q Diff
0.02
EPS Last/This Y
-0.33
EPS This/Next Y
0.52
Price
6.65
Target Price
26.25
Analyst Recom
1.22
Performance Q
-12.73
Relative Volume
0.75
Beta
-1.27
Ticker: DAWN
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-07-04 | DAWN | 6.8 | 0.27 | 0.00 | 4569 |
2025-07-07 | DAWN | 6.64 | 0.27 | 0.00 | 4562 |
2025-07-08 | DAWN | 6.61 | 0.27 | 0.00 | 4583 |
2025-07-09 | DAWN | 6.99 | 0.27 | 0.00 | 4596 |
2025-07-10 | DAWN | 7.18 | 0.27 | 0.30 | 4643 |
2025-07-11 | DAWN | 6.79 | 0.26 | 0.00 | 4676 |
2025-07-14 | DAWN | 6.93 | 0.26 | 0.00 | 4688 |
2025-07-15 | DAWN | 6.57 | 0.26 | 1.46 | 4690 |
2025-07-16 | DAWN | 6.61 | 0.26 | 0.00 | 4717 |
2025-07-17 | DAWN | 6.51 | 0.26 | 0.00 | 4819 |
2025-07-18 | DAWN | 6.41 | 0.25 | 0.00 | 4953 |
2025-07-21 | DAWN | 6.41 | 0.07 | 0.00 | 2728 |
2025-07-22 | DAWN | 6.58 | 0.07 | 0.00 | 2802 |
2025-07-23 | DAWN | 6.94 | 0.07 | 0.00 | 2858 |
2025-07-24 | DAWN | 7.22 | 0.06 | 0.13 | 3050 |
2025-07-25 | DAWN | 7.24 | 0.06 | 0.00 | 3098 |
2025-07-28 | DAWN | 7.11 | 0.06 | 0.03 | 3123 |
2025-07-29 | DAWN | 6.98 | 0.06 | 0.00 | 3219 |
2025-07-30 | DAWN | 6.86 | 0.06 | 0.00 | 3180 |
2025-07-31 | DAWN | 6.7 | 0.07 | 0.00 | 3143 |
2025-08-01 | DAWN | 6.64 | 0.06 | 0.10 | 3176 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-07-04 | DAWN | 6.80 | -591.0 | - | -1.36 |
2025-07-07 | DAWN | 6.64 | -591.0 | - | -1.36 |
2025-07-08 | DAWN | 6.61 | -591.0 | - | -1.36 |
2025-07-09 | DAWN | 7.00 | -591.0 | - | -1.36 |
2025-07-10 | DAWN | 7.19 | -591.0 | - | -1.36 |
2025-07-11 | DAWN | 6.79 | -591.0 | - | -1.36 |
2025-07-14 | DAWN | 6.93 | -591.0 | - | -1.36 |
2025-07-15 | DAWN | 6.57 | -591.0 | - | -1.36 |
2025-07-16 | DAWN | 6.61 | -591.0 | - | -1.36 |
2025-07-17 | DAWN | 6.50 | -591.0 | - | -1.36 |
2025-07-18 | DAWN | 6.41 | -591.0 | - | -1.36 |
2025-07-21 | DAWN | 6.40 | -591.0 | - | -1.36 |
2025-07-22 | DAWN | 6.58 | -591.0 | - | -1.36 |
2025-07-23 | DAWN | 6.94 | -591.0 | - | -1.36 |
2025-07-24 | DAWN | 7.21 | -591.0 | - | -1.36 |
2025-07-25 | DAWN | 7.23 | -591.0 | - | -1.35 |
2025-07-28 | DAWN | 7.19 | -586.1 | - | -1.35 |
2025-07-29 | DAWN | 6.99 | -586.1 | - | -1.35 |
2025-07-30 | DAWN | 6.87 | -586.1 | - | -1.35 |
2025-07-31 | DAWN | 6.71 | -586.1 | - | -1.35 |
2025-08-01 | DAWN | 6.65 | -586.1 | - | -1.35 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-07-04 | DAWN | -0.18 | 0.35 | 16.89 |
2025-07-07 | DAWN | -0.18 | 0.35 | 16.89 |
2025-07-08 | DAWN | -0.18 | 0.35 | 16.89 |
2025-07-09 | DAWN | -0.18 | 0.35 | 16.89 |
2025-07-10 | DAWN | -0.18 | 0.35 | 16.89 |
2025-07-11 | DAWN | -0.18 | 0.35 | 15.66 |
2025-07-14 | DAWN | -0.18 | 0.43 | 15.66 |
2025-07-15 | DAWN | -0.18 | 0.43 | 15.66 |
2025-07-16 | DAWN | -0.18 | 0.43 | 15.66 |
2025-07-17 | DAWN | -0.18 | 0.43 | 15.66 |
2025-07-18 | DAWN | -0.18 | 0.43 | 15.66 |
2025-07-21 | DAWN | -0.18 | 0.38 | 15.66 |
2025-07-22 | DAWN | -0.18 | 0.38 | 15.66 |
2025-07-23 | DAWN | -0.18 | 0.38 | 15.66 |
2025-07-24 | DAWN | -0.18 | 0.38 | 15.66 |
2025-07-25 | DAWN | -0.18 | 0.38 | 13.77 |
2025-07-28 | DAWN | -0.18 | -1.37 | 13.77 |
2025-07-29 | DAWN | -0.18 | -1.37 | 13.77 |
2025-07-30 | DAWN | -0.18 | -1.37 | 13.77 |
2025-07-31 | DAWN | -0.18 | -1.37 | 13.77 |
2025-08-01 | DAWN | -0.18 | -1.37 | 13.77 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.35
Avg. EPS Est. Current Quarter
-0.35
Avg. EPS Est. Next Quarter
-0.33
Insider Transactions
-0.18
Institutional Transactions
-1.37
Beta
-1.27
Average Sales Estimate Current Quarter
35
Average Sales Estimate Next Quarter
39
Fair Value
Quality Score
44
Growth Score
29
Sentiment Score
30
Actual DrawDown %
76.8
Max Drawdown 5-Year %
Target Price
26.25
P/E
Forward P/E
PEG
P/S
4.16
P/B
1.41
P/Free Cash Flow
EPS
-0.67
Average EPS Est. Cur. Y
-1.35
EPS Next Y. (Est.)
-0.83
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-42.66
Relative Volume
0.75
Return on Equity vs Sector %
-38.1
Return on Equity vs Industry %
-19.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading